176 related articles for article (PubMed ID: 38360959)
1. Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
Fujita N; Ushijima Y; Ishimatsu K; Okamoto D; Wada N; Takao S; Murayama R; Itoyama M; Harada N; Maehara J; Oda Y; Ishigami K; Nishie A
Abdom Radiol (NY); 2024 May; 49(5):1467-1478. PubMed ID: 38360959
[TBL] [Abstract][Full Text] [Related]
2. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Lee S; Kim SH; Lee JE; Sinn DH; Park CK
J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
[TBL] [Abstract][Full Text] [Related]
3. Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lim S; Choi SY; Lee J; Lee JE; Ha SY; Cha DI; Carriere KC; Ahn JH
Radiology; 2020 Dec; 297(3):573-581. PubMed ID: 32990512
[TBL] [Abstract][Full Text] [Related]
4. Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study.
Zhou M; Shan D; Zhang C; Nie J; Wang G; Zhang Y; Zhou Y; Zheng T
BMC Med Imaging; 2021 Mar; 21(1):40. PubMed ID: 33673821
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
[TBL] [Abstract][Full Text] [Related]
6. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Ahn SY; Lee JM; Joo I; Lee ES; Lee SJ; Cheon GJ; Han JK; Choi BI
Abdom Imaging; 2015 Apr; 40(4):843-51. PubMed ID: 25253426
[TBL] [Abstract][Full Text] [Related]
7. Nomogram for Predicting Microvascular Invasion in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI and Intravoxel Incoherent Motion Imaging.
Zhou L; Qu Y; Quan G; Zuo H; Liu M
Acad Radiol; 2024 Feb; 31(2):457-466. PubMed ID: 37491178
[TBL] [Abstract][Full Text] [Related]
8. Direct Comparison of Four Presurgical Stratifying Schemes for Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Gadoxetic Acid-Enhanced MRI.
Sun SW; Liu QP; Xu X; Zhu FP; Zhang YD; Liu XS
J Magn Reson Imaging; 2020 Aug; 52(2):433-447. PubMed ID: 31943465
[TBL] [Abstract][Full Text] [Related]
9. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
Chen Y; Xia Y; Tolat PP; Long L; Jiang Z; Huang Z; Tang Q
AJR Am J Roentgenol; 2021 Jun; 216(6):1510-1520. PubMed ID: 33826360
[No Abstract] [Full Text] [Related]
11. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
12. Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging.
Kim MJ; Lee M; Choi JY; Park YN
Eur J Radiol; 2012 Oct; 81(10):2507-12. PubMed ID: 22137613
[TBL] [Abstract][Full Text] [Related]
13. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images.
Min JH; Kim YK; Lim S; Jeong WK; Choi D; Lee WJ
Eur J Radiol; 2015 Jun; 84(6):1036-43. PubMed ID: 25818729
[TBL] [Abstract][Full Text] [Related]
14. Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study.
Rao C; Wang X; Li M; Zhou G; Gu H
BMC Med Imaging; 2020 Apr; 20(1):43. PubMed ID: 32345247
[TBL] [Abstract][Full Text] [Related]
15. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
Sun L; Mu L; Zhou J; Tang W; Zhang L; Xie S; Chen J; Wang J
Cancer Immunol Immunother; 2022 Jan; 71(1):25-38. PubMed ID: 33993366
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
[TBL] [Abstract][Full Text] [Related]
17. IVIM improves preoperative assessment of microvascular invasion in HCC.
Wei Y; Huang Z; Tang H; Deng L; Yuan Y; Li J; Wu D; Wei X; Song B
Eur Radiol; 2019 Oct; 29(10):5403-5414. PubMed ID: 30877465
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
19. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.
Ryu T; Takami Y; Wada Y; Tateishi M; Hara T; Yoshitomi M; Momosaki S; Yasumori K; Saitsu H; Okuda K
J Gastrointest Surg; 2019 Apr; 23(4):779-787. PubMed ID: 30788712
[TBL] [Abstract][Full Text] [Related]
20. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
Zhang L; Yu X; Wei W; Pan X; Lu L; Xia J; Zheng W; Jia N; Huo L
Eur Radiol; 2020 Oct; 30(10):5327-5336. PubMed ID: 32367417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
